Key facts
- This page summarizes Robert Wong's Form 4 filing for CYTOKINETICS INC (CYTK).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2024, 19:07.
Robert Wong - 14 Mar 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)
- Reporting relationship
- VP, Chief Accounting Officer
- Issuer ticker
- CYTK
- Reported as of
- 14 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Mar 2024, 19:07:33 UTC
- Prior SEC filing
- 07 Mar 2024
- Next SEC filing
- 03 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Faurescu, attorney-in-fact for Mr. Wong
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Wong filed Form 4 for CYTOKINETICS INC (CYTK) on 18 Mar 2024.
Change
- Previous filing in this sequence was filed on 07 Mar 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYTK
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,079
- Change %
- +16%
- Price
- $0.000000
- Shares after
- 29,664
- Date
- 14 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CYTK
transaction
Derivative
Incentive Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +1,403
- Change %
- Price
- $0.000000
- Shares after
- 1,403
- Date
- 14 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,403
- Exercise price
- $63.75
- Footnotes
- F2
CYTK
transaction
Derivative
Non-Qualified Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +3,308
- Change %
- Price
- $0.000000
- Shares after
- 3,308
- Date
- 14 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,308
- Exercise price
- $63.75
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Comprised of restricted stock units that will vest over 3 years, with 40% vesting on the 1-year anniversary of the grant, an additional 40% vesting on the 2-year anniversary of the grant, and the final 20% vesting on the 3-year anniversary of the grant.
Footnote F2
This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 15, 2024, with the final installment vesting on March 14, 2028.